AUD 0.05
(6.52%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 3.16 Million AUD | 70.54% |
2022 | 1.85 Million USD | 31.89% |
2021 | 1.4 Million AUD | 156.0% |
2020 | 550 Thousand AUD | -75.12% |
2019 | 2.21 Million AUD | 9.35% |
2018 | 2.02 Million AUD | -26.42% |
2017 | 2.74 Million AUD | 44.86% |
2016 | 1.89 Million AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 1.58 Million USD | -26.75% |
2024 Q2 | 1.58 Million USD | 0.0% |
2023 Q4 | 2.16 Million USD | -35.72% |
2023 Q2 | 3.01 Million USD | 0.37% |
2023 FY | 3.16 Million AUD | 70.54% |
2023 Q1 | 3 Million USD | 61.82% |
2023 Q3 | 3.36 Million USD | 11.45% |
2022 Q2 | 3.14 Million USD | 8.39% |
2022 Q4 | 1.85 Million USD | -36.04% |
2022 FY | 1.85 Million USD | 31.89% |
2022 Q1 | 2.9 Million USD | 106.33% |
2022 Q3 | 2.9 Million USD | -7.79% |
2021 Q1 | 1.38 Million USD | 94.31% |
2021 FY | 1.4 Million AUD | 156.0% |
2021 Q4 | 1.4 Million AUD | -27.74% |
2021 Q3 | 1.94 Million USD | 38.61% |
2021 Q2 | 1.4 Million USD | 1.3% |
2020 Q4 | 714.1 Thousand AUD | -7.05% |
2020 FY | 550 Thousand AUD | -75.12% |
2020 Q1 | 2.32 Million USD | 5.32% |
2020 Q2 | 2.07 Million USD | -10.89% |
2020 Q3 | 768.24 Thousand USD | -62.98% |
2019 Q4 | 2.21 Million AUD | -32.51% |
2019 FY | 2.21 Million AUD | 9.35% |
2019 Q3 | 3.27 Million USD | 47.9% |
2019 Q2 | 2.21 Million USD | 1.14% |
2019 Q1 | 2.19 Million USD | 8.31% |
2018 Q1 | 3.56 Million USD | 29.65% |
2018 Q3 | 2.79 Million USD | -24.35% |
2018 Q4 | 2.02 Million AUD | -27.72% |
2018 FY | 2.02 Million AUD | -26.42% |
2018 Q2 | 3.69 Million USD | 3.8% |
2017 Q2 | 3.31 Million USD | -0.6% |
2017 Q1 | 3.33 Million USD | 26.96% |
2017 FY | 2.74 Million AUD | 44.86% |
2017 Q4 | 2.74 Million AUD | -21.57% |
2017 Q3 | 3.5 Million USD | 5.61% |
2016 FY | 1.89 Million AUD | 0.0% |
2016 Q4 | 2.62 Million USD | 6.07% |
2016 Q3 | 2.47 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
4DMedical Limited | 992.24 Thousand AUD | -219.174% |
Adherium Limited | 1.58 Million AUD | -100.152% |
Aroa Biosurgery Limited | 7.43 Million AUD | 57.376% |
Atomo Diagnostics Limited | 1.83 Million AUD | -72.236% |
Anteris Technologies Ltd | 646.71 Thousand AUD | -389.707% |
Control Bionics Limited | 404.15 Thousand AUD | -683.619% |
CardieX Limited | 2.55 Million AUD | -24.026% |
Compumedics Limited | 13.21 Million AUD | 76.028% |
Cochlear Limited | 391.6 Million AUD | 99.191% |
CleanSpace Holdings Limited | 2.86 Million AUD | -10.522% |
Cyclopharm Limited | 10.12 Million AUD | 68.712% |
EMVision Medical Devices Ltd | - AUD | -Infinity% |
Nova Eye Medical Limited | 4.28 Million AUD | 26.057% |
HeraMED Limited | 361.61 Thousand AUD | -775.8% |
Imricor Medical Systems, Inc. | 2.46 Million AUD | -28.527% |
ImpediMed Limited | 759 Thousand AUD | -317.259% |
InhaleRx Limited | - AUD | -Infinity% |
LBT Innovations Limited | 1.61 Million AUD | -95.735% |
Micro-X Limited | 5.37 Million AUD | 41.123% |
Neurotech International Limited | - AUD | -Infinity% |
OncoSil Medical Limited | 391.67 Thousand AUD | -708.586% |
PolyNovo Limited | 8.97 Million AUD | 64.701% |
Respiri Limited | 2.75 Million AUD | -15.098% |
SomnoMed Limited | 6.28 Million AUD | 49.614% |
Universal Biosensors, Inc. | 4.37 Million AUD | 27.66% |
Uscom Limited | 623.62 Thousand AUD | -407.836% |